Zajączkowska, R.; Rojewska, E.; Ciechanowska, A.; Pawlik, K.; Ciapała, K.; Kocot-Kępska, M.; Makuch, W.; Wordliczek, J.; Mika, J.
Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain. Pharmaceuticals 2022, 15, 88.
https://doi.org/10.3390/ph15010088
AMA Style
Zajączkowska R, Rojewska E, Ciechanowska A, Pawlik K, Ciapała K, Kocot-Kępska M, Makuch W, Wordliczek J, Mika J.
Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain. Pharmaceuticals. 2022; 15(1):88.
https://doi.org/10.3390/ph15010088
Chicago/Turabian Style
Zajączkowska, Renata, Ewelina Rojewska, Agata Ciechanowska, Katarzyna Pawlik, Katarzyna Ciapała, Magdalena Kocot-Kępska, Wioletta Makuch, Jerzy Wordliczek, and Joanna Mika.
2022. "Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain" Pharmaceuticals 15, no. 1: 88.
https://doi.org/10.3390/ph15010088
APA Style
Zajączkowska, R., Rojewska, E., Ciechanowska, A., Pawlik, K., Ciapała, K., Kocot-Kępska, M., Makuch, W., Wordliczek, J., & Mika, J.
(2022). Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain. Pharmaceuticals, 15(1), 88.
https://doi.org/10.3390/ph15010088